Alkermes is a global biopharmaceutical company focused on developing and commercializing medicines for complex psychiatric and neurological disorders. Its therapeutic areas include addiction, serious mental illness, and sleep disorders. The company's work spans neuroscience, drug development, and pharmaceutical research.
The company maintains a portfolio of marketed medicines for psychiatric and neurological conditions, alongside an investigational pipeline of drug candidates in development for various disorders. Alkermes operates across the biotech, pharmaceuticals, neuroscience, psychiatry, and neurology industry verticals.
Alkermes describes its approach as patient-inspired science, guided by empathy for patients, families, and caregivers. The company has stated that collaboration is at its core and that its core values guide its culture. It has been recognized as an employer of choice in the biotech industry and emphasizes working with urgency.
